{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:20:05Z","timestamp":1790839205601,"version":"4.1.0"},"reference-count":46,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Breast Cancer\ufffd(Auckl)"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    While sentinel lymph node biopsy (SLNB) in breast cancer patients with limited axillary disease undergoing upfront surgery is well-accepted, there are insufficient data supporting its safety with residual nodal disease (RND) following neoadjuvant chemotherapy (NAC).\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To evaluate axillary management and oncologic outcomes of patients with RND.\n                    <jats:bold>Design:<\/jats:bold>\n                    A retrospective review comparing patients receiving SLNB to those receiving axillary lymph node dissection (ALND).\n                    <jats:bold>Methods:<\/jats:bold>\n                    Patients treated for breast cancer at our institution between 2015 and 2023, who received NAC and had RND, were identified. Patient and tumor characteristics, treatments, and outcomes information were collected. The relationship between axillary management and oncologic outcomes was examined.\n                    <jats:bold>Results:<\/jats:bold>\n                    Of 155 patients, median age was 55\u2009years (interquartile range [IQR] 46\u201364) and follow-up 56\u2009months (IQR 34\u201373). Most patients were pathologic tumor stage 1\u20132 (105, 67.7%) and nodal stage 1 (106, 68.4%), with ductal histology (127, 81.9%). The most common receptor pattern was estrogen receptor-positive, progesterone receptor-positive, and human epidermal growth factor receptor 2-negative. A total of 107 (69.0%) underwent mastectomy, 47 (30.3%) lumpectomy, and 138 (89.0%) received adjuvant radiation. Regarding axillary management, 121 (78.1%) underwent ALND and 34 (21.9%) SLNB. Univariate analysis found no differences in overall survival (68.6% vs 70.6%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20091), any recurrence (local, axillary, or distant; 36.4% vs 35.3%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20091), or specifically axillary recurrence (9.9% vs 8.8%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20091), between ALND and SLNB groups, respectively. This was also demonstrated on multivariate analysis. Conversely, there was a significantly increased rate of lymphedema in the ALND, 57.9%, vs the SLNB group, 35.3% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20090.03).\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    ALND was not associated with improved survival or recurrence risk compared with SLNB in patients with RND following NAC, but was found to have a higher rate of lymphedema. This study is limited due to its retrospective nature. Further data, such as from the ALLIANCE A011202 trial, will help to further clarify the optimal oncologic management for this group of patients.\n                  <\/jats:p>","DOI":"10.1177\/11782234251352996","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:26:16Z","timestamp":1754889976000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Axillary Lymph Node Dissection in Breast Cancer Patients With Residual Nodal Disease After Receiving Neoadjuvant Chemotherapy"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7201-663X","authenticated-orcid":false,"given":"Kristina","family":"Shaffer","sequence":"first","affiliation":[{"name":"Department of Surgery, The University of North Carolina School of Medicine, Chapel Hill, NC, USA"},{"name":"Department of Surgical Oncology, Novant Health Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Novant Health Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Gentile","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Novant Health Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Merrill","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Novant Health Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Kellam","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Novant Health Surgical Institute, Winston Salem, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fillion","sequence":"additional","affiliation":[{"name":"Department of Surgery, Novant Health New Hanover Regional Medical Center, Wilmington, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Turk","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of North Carolina School of Medicine, Chapel Hill, NC, USA"},{"name":"Department of Surgical Oncology, Novant Health Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-189407000-00075"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022152"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020128"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2020.09.001"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70207-2"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11470"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00687-1"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001375"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10986"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.11.019"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-5004-7"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz235"},{"key":"e_1_3_3_14_2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer. Version 1.2025. Plymouth Meeting 2025. Accessed June 18 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1419"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16143-6"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.11.099"},{"key":"e_1_3_3_17_2","unstructured":"Boughey J. Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy. Clinicaltrials; 2024. Accessed June 18 2025. https:\/\/clinicaltrials.gov\/study\/NCT01901094"},{"key":"e_1_3_3_18_2","unstructured":"Swiss Group for Clinical Cancer Research. Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS). U.S. National Library of Medicine; 2018. Accessed June 18 2025. https:\/\/clinicaltrials.gov\/study\/NCT03513614."},{"key":"e_1_3_3_19_2","unstructured":"STROBE Statement Group. Strengthening the Reporting of Observational Studies in Epidemiology. The EQUATOR Network; 2023. Accessed June 18 2025. https:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/."},{"key":"e_1_3_3_20_2","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2023."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03547-7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.524"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21349"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2644-2"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S176763"},{"key":"e_1_3_3_26_2","unstructured":"Mayrovitz HN. Breast cancer. Exon Publications; 2022. Accessed June 18 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK583818\/"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000205"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990250"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn386"},{"key":"e_1_3_3_30_2","first-page":"4332","article-title":"The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis","volume":"9","author":"Hormbrey E","year":"2003","unstructured":"Hormbrey E, Han C, Roberts A, McGrouther DA, Harris AL. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res. 2003;9:4332-4339.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181d2ad07"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01966"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09910-2"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70460-7"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-07183-9"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1742"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2024.0180"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010815)92:4<748::AID-CNCR1378>3.0.CO;2-V"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1155-4"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0347-2"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.231"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2021.24.e9"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.3725"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11324-7"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112620"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173001"}],"container-title":["Breast Cancer: Basic and Clinical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11782234251352996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11782234251352996","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11782234251352996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:56:48Z","timestamp":1777381008000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11782234251352996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":46,"alternative-id":["10.1177\/11782234251352996"],"URL":"https:\/\/doi.org\/10.1177\/11782234251352996","relation":{},"ISSN":["1178-2234","1178-2234"],"issn-type":[{"value":"1178-2234","type":"print"},{"value":"1178-2234","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,10]]},"article-number":"11782234251352996"}}